Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
Business Model:
Revenue: $7.2M
Employees: 2-10
Address: 36 Toronto Street
City: Toronto
State: ontario
Zip: M5C 2C5
Country: CA
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2017 | Therapeutic Monitoring Systems Inc. | Venture Round | - |
3/2007 | Affinium Pharmaceuticals | Series A | 18M |
2/2010 | Tioga Pharmaceuticals | Venture Round | 18M |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
12/2012 | Naurex | Series B | 0 |
12/2014 | Naurex | Series C | 0 |
12/2017 | Aptinyx | Series B | 70M |
8/2007 | NeurAxon | Series B | 32M |
7/2009 | Allostera Pharma | Series A | 14.6M |
10/2022 | Inversago Pharma | Series C | 0 |
2/2017 | Fusion Pharmaceuticals | Series A | 0 |
4/2015 | Profound Medical Inc | Venture Round | 0 |
9/2017 | Fusion Pharmaceuticals | Series A | 0 |
6/2021 | Veralox Therapeutics | Series A | 0 |
10/2014 | Invitae | Series F | 0 |
1/2020 | IDbyDNA | Series B | 0 |
5/2021 | Giiant Pharma | Seed Round | 0 |
9/2020 | Inversago Pharma | Series B | 0 |
7/2011 | gIcare Pharma | Series A | 7.4M |
7/2018 | Inversago Pharma | Series A | 0 |
5/2011 | Naurex | Series A | 18M |
1/2018 | Adapsyn Bioscience | Venture Round | - |
11/2019 | EBT Medical | Series A | 10M |
10/2011 | Functional Neuromodulation | Series A | 10.4M |
2/2006 | StemPath | Venture Round | 1M |
1/2018 | Flosonics | Equity | 5M |
12/2013 | Invitae | Series E | 0 |
4/2012 | Tioga Pharmaceuticals | Series B | 10M |
2/2021 | Flosonics | Venture Round | 0 |
7/2004 | NeurAxon | Series A | 1.9M |
8/2006 | Millenium Biologix | Venture Round | 0 |
6/2021 | Veralox Therapeutics | Series A | 0 |
5/2021 | Giiant Pharma | Seed Round | 0 |
2/2021 | Flosonics | Venture Round | 0 |
9/2020 | Inversago Pharma | Series B | 0 |
1/2020 | IDbyDNA | Series B | 0 |
11/2019 | EBT Medical | Series A | 0 |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
7/2018 | Inversago Pharma | Series A | 0 |
1/2018 | Flosonics | Seed Round | 0 |
1/2018 | Adapsyn Bioscience | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|